JP2020531529A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531529A5
JP2020531529A5 JP2020511359A JP2020511359A JP2020531529A5 JP 2020531529 A5 JP2020531529 A5 JP 2020531529A5 JP 2020511359 A JP2020511359 A JP 2020511359A JP 2020511359 A JP2020511359 A JP 2020511359A JP 2020531529 A5 JP2020531529 A5 JP 2020531529A5
Authority
JP
Japan
Prior art keywords
organ
perfusion system
organ perfusion
ppm
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020511359A
Other languages
English (en)
Japanese (ja)
Other versions
JP7249331B2 (ja
JP2020531529A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/048028 external-priority patent/WO2019040921A1/en
Publication of JP2020531529A publication Critical patent/JP2020531529A/ja
Publication of JP2020531529A5 publication Critical patent/JP2020531529A5/ja
Priority to JP2022123251A priority Critical patent/JP2022140622A/ja
Application granted granted Critical
Publication of JP7249331B2 publication Critical patent/JP7249331B2/ja
Priority to JP2024137625A priority patent/JP2024159817A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020511359A 2017-08-25 2018-08-24 器官の生存率を改善する方法 Active JP7249331B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022123251A JP2022140622A (ja) 2017-08-25 2022-08-02 器官の生存率を改善する方法
JP2024137625A JP2024159817A (ja) 2017-08-25 2024-08-19 器官の生存率を改善する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762550463P 2017-08-25 2017-08-25
US62/550,463 2017-08-25
PCT/US2018/048028 WO2019040921A1 (en) 2017-08-25 2018-08-24 METHODS OF ENHANCING VIABILITY OF AN ORGAN

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022123251A Division JP2022140622A (ja) 2017-08-25 2022-08-02 器官の生存率を改善する方法

Publications (3)

Publication Number Publication Date
JP2020531529A JP2020531529A (ja) 2020-11-05
JP2020531529A5 true JP2020531529A5 (enExample) 2021-08-05
JP7249331B2 JP7249331B2 (ja) 2023-03-30

Family

ID=65434015

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020511359A Active JP7249331B2 (ja) 2017-08-25 2018-08-24 器官の生存率を改善する方法
JP2022123251A Pending JP2022140622A (ja) 2017-08-25 2022-08-02 器官の生存率を改善する方法
JP2024137625A Pending JP2024159817A (ja) 2017-08-25 2024-08-19 器官の生存率を改善する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022123251A Pending JP2022140622A (ja) 2017-08-25 2022-08-02 器官の生存率を改善する方法
JP2024137625A Pending JP2024159817A (ja) 2017-08-25 2024-08-19 器官の生存率を改善する方法

Country Status (9)

Country Link
US (4) US11044904B2 (enExample)
EP (1) EP3672403A4 (enExample)
JP (3) JP7249331B2 (enExample)
KR (2) KR102708577B1 (enExample)
CN (1) CN111107742A (enExample)
AU (2) AU2018322317B2 (enExample)
CA (1) CA3073399A1 (enExample)
MX (1) MX2020001853A (enExample)
WO (1) WO2019040921A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3030789A1 (en) 2016-07-13 2018-01-18 The Trustees Of Columbia University In The City Of New York Cross-circulation platform for recovery, regeneration, and maintenance of extracorporeal organs
AU2018322317B2 (en) * 2017-08-25 2023-11-23 Mallinckrodt Pharmaceuticals Ireland Limited Methods to improve organ viability
CN110583620A (zh) * 2019-08-26 2019-12-20 广东顺德工业设计研究院(广东顺德创新设计研究院) 离体肺脏机械灌注的调温设备及方法、装置
CN112106766B (zh) * 2020-11-18 2021-03-12 中山大学附属第一医院 一种离体心肺联合灌注系统及灌注方法
CN118142012B (zh) * 2024-03-20 2025-05-13 中国人民解放军总医院第四医学中心 离断肢体血液交叉循环系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338662A (en) * 1992-09-21 1994-08-16 Bio-Preserve Medical Corporation Organ perfusion device
GB9908335D0 (en) * 1999-04-12 1999-06-09 Univ Cambridge Tech Methods and means for extracorporeal organ perfusion
AU2001241908A1 (en) * 2000-03-08 2001-09-17 Frederick A. Gage Kidney perfusion solution containing nitric oxide donor
MXPA03012031A (es) 2001-06-21 2005-07-01 Univ Yale El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis.
US7504201B2 (en) * 2004-04-05 2009-03-17 Organ Recovery Systems Method for perfusing an organ and for isolating cells from the organ
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs
JP4935242B2 (ja) * 2006-08-24 2012-05-23 ニプロ株式会社 脂肪酸を含有するｓ−ニトロソタンパク質とその製法
WO2008063868A2 (en) 2006-11-07 2008-05-29 The General Hospital Corporation Attenuation of vasoactive oxygen carrier-induced vasoconstriction
JP2010530001A (ja) 2007-06-15 2010-09-02 イカリア， インコーポレイテッド 硫化物単独または一酸化窒素との組み合わせを含む組成物およびその使用
AU2011336358B2 (en) 2010-12-03 2016-09-29 VERO Biotech LLC. Nitric oxide treatments
US9629358B2 (en) * 2013-03-15 2017-04-25 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids
JP2019505569A (ja) 2015-12-10 2019-02-28 ベロ バイオテック エルエルシー 血漿遊離ヘモグロビンを除去するための方法及び装置
DE102017204681A1 (de) 2017-03-21 2018-09-27 Robert Bosch Gmbh Vorrichtung zum Auslösen einer externen Schutzfunktion
AU2018322317B2 (en) * 2017-08-25 2023-11-23 Mallinckrodt Pharmaceuticals Ireland Limited Methods to improve organ viability

Similar Documents

Publication Publication Date Title
JP2020531529A5 (enExample)
Lentine et al. OPTN/SRTR 2021 annual data report: kidney
Ceresa et al. The case for normothermic machine perfusion in liver transplantation
van Beekum et al. Normothermic machine perfusion (NMP) of the liver–current status and future perspectives
Ceresa et al. Transient cold storage prior to normothermic liver perfusion may facilitate adoption of a novel technology
Minasian et al. Preservation of the donor heart: from basic science to clinical studies
Valero et al. Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non‐heart‐beating donors
US20070202083A1 (en) Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
Messner et al. Emerging technologies in organ preservation, tissue engineering and regenerative medicine: a blessing or curse for transplantation?
US20140314881A1 (en) Novel medical uses for no and no donor compounds
Gurusamy et al. Current protective strategies in liver surgery
Ostróżka-Cieślik et al. Tips for optimizing organ preservation solutions
AU722855B2 (en) Compositions for the preservation of living biological materials and methods of their use
CN108902131A (zh) 一种用于离体心脏保存的常温灌注液
Yamaoka et al. Organ preservation using a photosynthetic solution
US20160051581A1 (en) Delivery of argon to a recipient of biological material
US20180295833A1 (en) Method for suppression of or protection from ischemia/reperfusion injury of organs for transplantation
Juriasingani et al. Novel therapeutic strategies for renal graft preservation and their potential impact on the future of clinical transplantation
Yemaneberhan et al. Beyond the icebox: modern strategies in organ preservation for transplantation
EP3406139A1 (en) Method for genetically modifying a vascularised tissue
Gao et al. Research progress on hepatic machine perfusion
Yamada et al. Regulatory T cells induce persistent acceptance by IL-2 complexes after mouse lung transplantation
Niroomand et al. Machine Perfusion and Bioengineering Strategies in Transplantation—Beyond the Emerging Concepts
Hosgood et al. Current basic research in normothermic machine perfusion
Wang et al. Practical applications of hemoglobin-based oxygen carriers in organ transplantation